Cholestyramine for Oral Suspension

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62135-008
  • Package NDC 62135-008-56
  • Application number ANDA074561
  • SPL ID f1d8692b-deb3-d55f-e053-2a95a90ae615
  • SPL set ID 80db0042-0c05-4509-8a6b-fa9f4783629a
  • UNII 4B33BGI082
  • RxCUI 848943
  • RxCUI 1801279

What the source publishes

Labeler
Chartwell RX, LLC
Active ingredients
Cholestyramine for Oral Suspension
Form
POWDER
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62135-008_f1d8692b-deb3-d55f-e053-2a95a90ae615
{
  "name": "Cholestyramine for Oral Suspension",
  "splId": "f1d8692b-deb3-d55f-e053-2a95a90ae615",
  "labels": [
    {
      "setId": "80db0042-0c05-4509-8a6b-fa9f4783629a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80db0042-0c05-4509-8a6b-fa9f4783629a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80db0042-0c05-4509-8a6b-fa9f4783629a"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Chartwell RX, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "378 g in 1 CAN (62135-008-56)",
      "package_ndc": "62135-008-56",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230103"
    }
  ],
  "productId": "62135-008_f1d8692b-deb3-d55f-e053-2a95a90ae615",
  "useDomain": "unknown",
  "dosageForm": "POWDER",
  "productNdc": "62135-008",
  "deaSchedule": null,
  "genericName": "Cholestyramine for Oral Suspension",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CHOLESTYRAMINE",
      "strength": "4 g/9g"
    }
  ],
  "applicationNumber": "ANDA074561",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19960815",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000180292",
      "N0000175365"
    ],
    "upc": [
      "0362135008567",
      "0362135937546"
    ],
    "unii": [
      "4B33BGI082"
    ],
    "rxcui": [
      "848943",
      "1801279"
    ],
    "spl_set_id": [
      "80db0042-0c05-4509-8a6b-fa9f4783629a"
    ],
    "pharm_class_epc": [
      "Bile Acid Sequestrant [EPC]"
    ],
    "pharm_class_moa": [
      "Bile-acid Binding Activity [MoA]"
    ],
    "manufacturer_name": [
      "Chartwell RX, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62135-008_f1d8692b-deb3-d55f-e053-2a95a90ae615"